News | January 23, 2024
Cipla posts Q3 FY24 consolidated PAT at Rs. 1,055.90 Cr
Cipla has reported total income of Rs. 6,788.44 crores during the period ended December 31, 2023
Cipla has reported total income of Rs. 6,788.44 crores during the period ended December 31, 2023
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 85.41 crores during the period ended December 31, 2023
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Marks remarkable acceleration in innovation using AI technology
US FDA approval based on NEURO-TTRansform Phase III results
Subscribe To Our Newsletter & Stay Updated
